vimarsana.com

Page 18 - அமெரிக்கன் சமூகம் ஆஃப் மயக்க மருந்து நிபுணர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Top Penny Stocks To Watch For 2021 If You re Following Mushroom Stocks

Havn is one of the companies we’ve discussed plenty of times in the past. One of the things that initially attracted attention was its Chairman of the Board of Directors. Vic Neufeld assumed the role last year and brought with him a founder’s mentality. Most notably, Neufeld was credited with leading Aphria (NASDAQ: APHA) on its path of success during the early days of cannabis legalization. He now has put his focus on the psychedelic industry. However, Havn is obviously more than just 1 person. The company itself has begun rolling out its first retail products already. In fact, last month, the company announced a product listing agreement for product sales in select Nesters Markets in British Columbia. “This is a major milestone for Havn Retail, enabling us to reach our goal of launching our initial product line in the market for early 2021,” said Tim Moore, CEO of Havn Life.

Orthopedic practice OrthoBethesda names Dr Emil Engels as its CEO

Plus: Playseum closing in Bethesda By Dan Schere | January 19, 2021 Bethesda orthopedic practice names CEO OrthoBethesda, an orthopedic services provider with locations in Bethesda and Arlington, has appointed Dr. Emil Engels as its CEO. Engels will oversee OrthoBethesda’s operations in both locations, according to a press release. Engels has more than 20 years of experience leading clinical and business professionals, the press release said. He previously worked in multiple positions with Mednax, a national health solutions partner. Most recently, he was president. Engels has also been a health care consultant, served on the board of directors for the American Society of Anesthesiologists and received multiple awards for articles he has published about anesthesiology, the press release stated.

Top Wilmington supporters remain faithful to Rouzer, as state corporations drop him from donor list

David Rouzer and President Trump aboard Air Force One in March. (Port City Daily/Courtesy Wikimedia Commons) SOUTHEASTERN NC In the wake of the attack on the U.S. Capitol, Rep. David Rouzer is losing the support of the state’s most powerful corporations. Yet, Wilmington’s most powerful family and Rouzer’s biggest donor is standing by their man. “We support David,” Scott Sullivan responded Friday when asked if his company, Jh Land LLC, fully supports Rouzer after the congressman challenged the certification of President-elect Joe Biden’s victory. Jh Land LLC is one part of the Cameron family’s large portfolio of businesses in the Wilmington area and donated $21,200 to Rouzer’s campaign in the most-recent election cycle, according to Federal Election Commission data released Dec. 26. 

Bill calls for banning incapacitations of S C criminal suspects with ketamine

Bill calls for banning incapacitations of S.C. criminal suspects with ketamine More than a year after a man’s death in Charleston County, legislation has been introduced at the state level that could impact how first responders administer a sedative that is increasingly being utilized. (Source: Live 5 News) By Jared Kofsky and Lisa Weismann | January 14, 2021 at 4:40 PM EST - Updated January 14 at 6:35 PM CHARLESTON, S.C. (WCSC) - More than a year after a man’s death in Charleston County, legislation has been introduced at the state level that could impact how first responders administer a sedative that is increasingly being utilized.

Enalare Therapeutics Completes Formation of Its Scientific Advisory Board

Enalare Therapeutics Completes Formation of Its Scientific Advisory Board Posted Jan 13, 2021 The Appointments of Professors Albert Dahan MD, PhD and Tong Joo (TJ) Gan MD, MHS, MBA  Highlight a World Class Collection of Medical and Pharmaceutical Industry Experts  PRINCETON, N.J., January 12, 2021 – Enalare Therapeutics Inc., a clinical stage  biopharmaceutical company dedicated to developing novel therapies for patients suffering  from acute respiratory conditions, announced today that it has completed formation of its  scientific advisory board.  The Company is very pleased to welcome Albert Dahan MD, PhD, Tong Joo (TJ) Gan MD, Robert Raffa PhD, Eugene Vortsman DO, David Battleman MD, and Alexander Krause PhD to the organization as it advances the development of its lead product ENA-001 for several life-threatening indications involving respiratory depression. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.